Signalife (Los Angeles) said it has filed its Form 25 with the Securities and Exchange Commission affecting the withdrawal of trading of its common stock on the American Stock Exchange (AMEX). Signalife's common stock will trade the last day on Sept. 12 on AMEX.
The company said it expects that its common stock will be available for quotation on both the OTC Bulletin Board and the Pink Sheets, upon the opening of the market Sept. 15. OTCBB will assign a new trading symbol for Signalife common stock following the close of trading on AMEX.
Signalife develops continuous biomedical signal monitoring technology.
RadNet (Los Angeles), a provider of diagnostic imaging services through a network of imaging centers, said it completed its reincorporation in the State of Delaware from the State of New York on Sept. 3. The reincorporation did not result in any change to the company's name, ticker symbol, CUSIP number, business, management, executive officers, assets, liabilities or net worth.
"We're pleased to complete the reincorporation, and we thank RadNet, Inc. shareholders for their support," said Howard Berger, MD, CEO of RadNet.
The RadNet New York shareholders approved the reincorporation at the conclusion of the annual meeting on June 12. In the reincorporation, each outstanding share of common stock of RadNet New York was converted into one share of common stock of RadNet Delaware, and RadNet New York ceased to exist. Stockholders do not need to exchange their stock certificates.
Development group breaks ground in Colorado
Developer Forest City Science + Technology Group (Aurora, Colorado) broke ground at the Colorado Science + Technology Park at Fitzsimons, a business park dedicated to life science-focused companies, by demolishing the old Fitzsimons smokestack to make way for new scientific facilities. Plans call for Forest City's first life science building that will accommodate the growth of the region's existing life science industry as well as existing incubator tenants on site.
In addition, Aurora Mayor Ed Tauer unveiled an updated economic study predicting $3.5 billion in annual economic output in 2008 and up to $4.5 billion in annual economic impact by 2013 from the former Fitzsimons Army Medical Center, which now includes the Science + Technology Park, the Anschutz Medical Campus, The Children's Hospital and Research Center, and the future Veterans Affairs Hospital.
"The build-out of the Colorado Science + Technology Park at Fitzsimons is an important part of a grand vision to bring science and business together in one square mile that is fast becoming one of the most advanced life science communities in the world," said Tauer. "According to our latest economic study, developments at Fitzsimons and the Anschutz Medical Campus will yield 20,000 on-site jobs by 2013 and more than 43,000 on-site jobs when fully developed."